Z. Feng

MAPRE1 promotes cell cycle progression of hepatocellular carcinoma cells by interacting with CDK2

Hao Shen, Xing-Hua Liang, Z. Feng, 2020, Cell biology international.

SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling

Lan-Zeng Wang, Zhuojun Zhang, Xuhong Chen, 2022, British Journal of Cancer.

Extracellular vesicles-transferred SBSN drives glioma aggressiveness by activating NF-κB via ANXA1-dependent ubiquitination of NEMO

Jinbao Liu, D. Tang, Lan-Zeng Wang, 2022, Oncogene.

SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing

Ling Qi, Z. Feng, Jizhong Wang, 2021, Theranostics.

Advances in the study of aerobic glycolytic effects in resistance to radiotherapy in malignant tumors

Z. Feng, Honghao Chen, Yuyi Liu, 2023, PeerJ.

miR-30a inhibits epithelial-mesenchymal transition and metastasis in triple-negative breast cancer by targeting ROR1

Longhua Chen, Z. Feng, Xin Wang, 2018, Oncology reports.

Identification of potential biomarkers for diagnosis of hepatocellular carcinoma

Hao Shen, Xing-Hua Liang, Z. Feng, 2021, Experimental and therapeutic medicine.

Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF-κB activation via disrupting multiple-site ubiquitination of NEMO

Lan-Zeng Wang, Zhuojun Zhang, chunxiao yang, 2023, Cellular & Molecular Biology Letters.